Communiqués Hemogenyx Pharmaceuticals Plc

Actions

SILF

GB00BQVXM815

Recherche biotechnologique et médicale

Marché Fermé - London S.E. 17:35:14 28/08/2026			Varia. 5j.	Varia. 1 janv.
564,00 ^GBX	+1,44%		-5,05%	-1,40%

11/08	Actualités East Star Verkhuba ; accord de distribution pour BSF	AN
11/08	Hemogenyx Pharmaceuticals conclut un partenariat pour la production et la commercialisation d'une thérapie CAR-T en Estonie	MT

Communiqués

11/08	Hemogenyx Pharmaceuticals PLC Announces Collaboration with Cellin Technologies	AQ
29/07	Hemogenyx Pharmaceuticals PLC Announces Collaboration and Company Update	AQ
05/06	Hemogenyx Pharmaceuticals PLC Announces Notice of AGM	AQ
29/05	Hemogenyx Pharmaceuticals PLC Announces Grant of Options and Extension of Warrant Term	AQ
30/04	Hemogenyx Pharmaceuticals PLC Announces Final Results	AQ
28/04	Hemogenyx Pharmaceuticals PLC Announces Institutional Fundraise	AQ
14/04	Hemogenyx Pharmaceuticals PLC Announces Annual IND Report with FDA	AQ
31/03	Hemogenyx Pharmaceuticals PLC Announces Tech Transfer Completion and Clinical Trial Update	AQ
08/05/25	Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director’s Dealing	AQ
06/05/25	Hemogenyx Pharmaceuticals : AGM Notice (2025 AGM)	PU
06/05/25	Hemogenyx Pharmaceuticals : Proxy Form (2025 AGM)	PU
02/05/25	Hemogenyx Pharmaceuticals PLC Announces Second Patient Treated with HG-CT-1 CAR-T Therapy	AQ
28/04/25	Hemogenyx Pharmaceuticals PLC Announces Final Results	AQ
03/04/25	Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report	AQ
10/12/24	Hemogenyx Pharmaceuticals : Resolutions passed at Extraordinary General Meeting of Hemogenyx Pharmaceuticals plc on 9 December 2024	PU
10/12/24	Hemogenyx Pharmaceuticals : Result of Extraordinary General Meeting	PU
22/11/24	Hemogenyx Pharmaceuticals : Notice of Extraordinary General Meeting	PU
22/11/24	Hemogenyx Pharmaceuticals : Proxy Form (December 2024 EGM)	PU
22/11/24	Hemogenyx Pharmaceuticals : EGM Notice (December 2024 EGM)	PU
30/09/24	Hemogenyx Pharmaceuticals plc - Half-year Report	AQ
29/04/24	Hemogenyx Pharmaceuticals outlines significant progress with HEMO-CAR-T in 2023	AQ
12/03/24	Hemogenyx Pharmaceuticals discusses successful Ã‚£3.5M capital raise as it advances HEMO-CAR-T program	AQ
20/02/24	Hemogenyx Pharmaceuticals achieves breakthrough with HEMO-CAR-T program, CBR platform	AQ
19/02/24	Hemogenyx Pharmaceuticals PLC Announces CBR Brain Delivery	AQ
17/01/24	Hemogenyx Pharmaceuticals plc - Submission of Complete Response to Clinical Hold for HEMO-CAR-T IND	AQ